Tambe Moves Up To Lead Biocon Biologics
Replaces CEO Arun Chandavarkar, Who Will Continue To Serve As Director
Shreehas Tambe has been named as CEO of Biocon Biologics, taking over from Arun Chandavarkar, in the wake of the company’s milestone $3bn transaction for Viatris’s biosimilars business.
